Exploiting the Immunological Environment Supporting HIV-1 BnAb Induction During Infection to Inform Vaccine Design

Jun 3, 2021 8:25am ‐ Jun 3, 2021 8:50am

Speaker(s):


Designing Immunization Regimens to Promote the Germinal Center Response

Jun 3, 2021 8:50am ‐ Jun 3, 2021 9:15am

Speaker(s):


Targeting HIV-1 ENV V2-apex bNAb Precursors in Human Ig Knock-in Mouse Models

Jun 3, 2021 9:15am ‐ Jun 3, 2021 9:40am

Speaker(s):


Short Talk: HLA-II Associated Viral Adaptation Impacts the Quantity and Quality of CD4+ T-Cell Responses in HIV-1 Vaccine Recipients

Jun 3, 2021 9:40am ‐ Jun 3, 2021 9:55am

Speaker(s):


Short Talk: Sequential Immunization Strategies To Elicit Anti HIV-1 Broadly Neutralizing Antibodies

Jun 3, 2021 9:55am ‐ Jun 3, 2021 10:10am

Speaker(s):


Short Talk: Fusion Peptide Priming and Long Trimer Interval Reduces Off-target Antibody Responses Toward the HIV-1 Trimer Base Region

Jun 3, 2021 10:10am ‐ Jun 3, 2021 10:25am

Speaker(s):


Coffee Break

Jun 3, 2021 10:25am ‐ Jun 3, 2021 10:45am

Latest Developments in CMV-Vectored HIV/SIV Vaccines

Jun 3, 2021 10:45am ‐ Jun 3, 2021 11:10am

Speaker(s):


CD8 T Cell Inducing Vaccines

Jun 3, 2021 10:45am ‐ Jun 3, 2021 12:25pm

Co-Chair(s):


Understanding HLA-E Mediated Antigen Presentation to Inform Vaccine Design

Jun 3, 2021 11:10am ‐ Jun 3, 2021 11:35am

Speaker(s):